Saturday, July 11, 2026

pharma · Calculus, Dental · Oral Malodor

Colgate Oral Pharmaceuticals

Colgate Oral Pharmaceuticals clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

AU HQ
TGA registrant Type
Company details
Status
Public
HQ
AU
Programs
2
Drugs
0
Patents
0
Intelligence · Clinical Programs

Colgate Oral Pharmaceuticals projects

2 ClinicalTrials.gov programs sponsored by Colgate Oral Pharmaceuticals.

Colgate Oral Pharmaceuticals has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 0.454% stannous fluoride

    Colgate Oral Care

    Calculus, Dental

    phase 3 small molecule completed

    1 trial
  2. 0.454% stannous fluoride

    Colgate Oral Care

    Oral Malodor

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Colgate Oral Pharmaceuticals have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.